Boston Scientific Rhythmand Neuro — Goodwill decreased by 0.1% to $3.50B in Q4 2021 compared to the prior quarter.
An increase suggests recent acquisitions in the neuro and cardiac rhythm space, while a decrease may indicate impairment or divestiture.
Represents the carrying value of goodwill specifically allocated to the Rhythm and Neuro business segment. This asset ar...
Common in medical device companies that grow through M&A; peers like Medtronic or Abbott report similar segment-level goodwill.
bsx_segment_rhythm_and_neuro_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $3.12B | $3.51B | $3.50B |
| QoQ Change | — | +12.4% | -0.1% |